Trial reportJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG2025
Treating cellulitis promptly with compression therapy reduces C-reactive protein-levels and symptoms - a randomized-controlled trial.
Trial report in Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Treating cellulitis promptly with compression therapy reduces C-reactive protein-levels and symptoms - a randomized-controlled trial.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2025Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesCellulitis is an acute bacterial infection of the skin. Initial treatment primarily consists of systemic antibiotic therapy. Compression therapy is subsequently introduced to reduce edema. However, the optimal timing for initiating compression therapy remains a subject of debate, as early application is thought to potentially exacerbate the infection. PATIENTS AND
methodsThis study was designed as a prospective, randomized controlled trial. Patients admitted for treatment of lower leg cellulitis were recruited and randomly assigned in a 1:1 ratio. In addition to standard therapy, the intervention group received compression therapy one day after initiation of antibiotic treatment, using medical adaptive compression wraps. C-reactive protein (CRP) levels, reduction in erythema, and patient-reported symptoms were recorded.
resultsA total of 34 patients were included in the analysis. Early application of medical adaptive compression wraps alleviated symptoms without causing complications. In patients with initial CRP levels above 50 mg/dl at admission, CRP reduction occurred more rapidly.
conclusionsOur data suggest that the early application of medical adaptive compression wraps within 24 hours of initiating antibiotic treatment alleviates symptoms, supports recovery, and does not lead to worsening of inflammation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.